- Product NDC
- 67871-007
- 11-digit product format
- 678710007
- Labeler code
- 67871
- Product ID
- 67871-007_6b61a6f9-0cc7-47bf-a600-ae8bb89a9501
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- sodium cation, sodium bicarbonate, anhydrous dextrose, magnesium sulfate, potassium chloride, calcium chloride, sodium phosphate
- Dosage form
- INJECTION
- Route
- INTRATHECAL
- Labeler
- QOL Medical, LLC
- Application
- NDA020577
- Marketing category
- NDA
- Marketing start
- 2006-09-27
- Marketing end
- 0000-00-00
- Substance
- SODIUM CHLORIDE; SODIUM BICARBONATE; ANHYDROUS DEXTROSE; MAGNESIUM SULFATE; POTASSIUM CHLORIDE; CALCIUM CHLORIDE; SODIUM PHOSPHATE
- Active strength
- 73 mg/10mL; mg/10mL; mg/10mL; mg/10mL; mg/10mL; mg/10mL; mg/10mL
- Pharmacologic classes
- Osmotic Laxative [EPC],Increased Large Intestinal Motility [PE],Inhibition Large Intestine Fluid/Electrolyte Absorption [PE],Osmotic Activity [MoA],Calculi Dissolution Agent [EPC],Magnesium Ion Exchange Activity [MoA],Osmotic Laxative [EPC],Osmotic Activity [MoA],Inhibition Small Intestine Fluid/Electrolyte Absorption [PE],Increased Large Intestinal Motility [PE],Stimulation Large Intestine Fluid/Electrolyte Secretion [PE],Inhibition Large Intestine Fluid/Electrolyte Absorption [PE],Potassium Compounds [CS],Potassium Salt [EPC],Osmotic Laxative [EPC],Increased Large Intestinal Motility [PE],Inhibition Large Intestine Fluid/Electrolyte Absorption [PE],Osmotic Activity [MoA],Blood Coagulation Factor [EPC],Increased Coagulation Factor Activity [PE],Calcium [CS],Cations, Divalent [CS]
- NDC exclude flag
- E
- Listing certified through
- 2017-12-31
- Current FDA listing
- Historical FDA.report record